Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 394

1.

Clinical Differences in Japanese Patients Between Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy With Long-Term Follow-Up.

Kataoka N, Nagase S, Kamakura T, Nakajima K, Wada M, Yamagata K, Ishibashi K, Inoue YY, Miyamoto K, Noda T, Aiba T, Izumi C, Noguchi T, Yasuda S, Kamakura S, Kusano K.

Am J Cardiol. 2019 Sep 1;124(5):715-722. doi: 10.1016/j.amjcard.2019.05.067. Epub 2019 Jun 12.

PMID:
31284935
2.

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr; REGAIN Study Group.

Qual Life Res. 2019 Aug;28(8):2255. doi: 10.1007/s11136-019-02204-x.

3.

First clinical application of octacalcium phosphate collagen composite on bone regeneration in maxillary sinus floor augmentation: A prospective, single-arm, open-label clinical trial.

Miura KI, Sumita Y, Kajii F, Tanaka H, Kamakura S, Asahina I.

J Biomed Mater Res B Appl Biomater. 2019 Apr 13. doi: 10.1002/jbm.b.34384. [Epub ahead of print]

PMID:
30980703
4.

Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr; REGAIN Study Group.

Qual Life Res. 2019 Aug;28(8):2247-2254. doi: 10.1007/s11136-019-02148-2. Epub 2019 Mar 23. Erratum in: Qual Life Res. 2019 May 21;:.

5.

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.

Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain Study Group.

Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8.

6.

Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.

Shimizu W, Makimoto H, Yamagata K, Kamakura T, Wada M, Miyamoto K, Inoue-Yamada Y, Okamura H, Ishibashi K, Noda T, Nagase S, Miyazaki A, Sakaguchi H, Shiraishi I, Makiyama T, Ohno S, Itoh H, Watanabe H, Hayashi K, Yamagishi M, Morita H, Yoshinaga M, Aizawa Y, Kusano K, Miyamoto Y, Kamakura S, Yasuda S, Ogawa H, Tanaka T, Sumitomo N, Hagiwara N, Fukuda K, Ogawa S, Aizawa Y, Makita N, Ohe T, Horie M, Aiba T.

JAMA Cardiol. 2019 Mar 1;4(3):246-254. doi: 10.1001/jamacardio.2018.4925.

PMID:
30758498
7.

Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.

Nagayama T, Nagase S, Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Noda T, Aiba T, Takaki H, Sugimachi M, Shimizu W, Noguchi T, Yasuda S, Kamakura S, Kusano K.

Circ J. 2019 Feb 25;83(3):532-539. doi: 10.1253/circj.CJ-18-0643. Epub 2019 Jan 12.

8.

Low-Voltage Type 1 ECG Is Associated With Fatal Ventricular Tachyarrhythmia in Brugada Syndrome.

Nagase S, Kamakura T, Kataoka N, Wada M, Yamagata K, Ishibashi K, Inoue YY, Miyamoto K, Noda T, Aiba T, Izumi C, Noguchi T, Yasuda S, Shimizu W, Kamakura S, Kusano K.

J Am Heart Assoc. 2018 Nov 6;7(21):e009713. doi: 10.1161/JAHA.118.009713.

9.

Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy.

Nakajima I, Noda T, Kanzaski H, Kamakura T, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Okamura H, Nagase S, Aiba T, Kamakura S, Noguchi T, Yasuda S, Akashi YJ, Kusano KF.

JACC Clin Electrophysiol. 2018 Sep;4(9):1227-1234. doi: 10.1016/j.jacep.2018.06.010. Epub 2018 Jul 25.

10.

Bone regeneration by freeze-dried composite of octacalcium phosphate collagen and teriparatide.

Iwai A, Kajii F, Tanaka H, Sasaki K, Matsui K, Kawai T, Kamakura S.

Oral Dis. 2018 Nov;24(8):1514-1521. doi: 10.1111/odi.12923. Epub 2018 Jul 10.

PMID:
29943386
11.

Differential cell surface recruitment of the superoxide-producing NADPH oxidases Nox1, Nox2 and Nox5: The role of the small GTPase Sar1.

Kiyohara T, Miyano K, Kamakura S, Hayase J, Chishiki K, Kohda A, Sumimoto H.

Genes Cells. 2018 Jun;23(6):480-493. doi: 10.1111/gtc.12590. Epub 2018 May 2.

12.

Significance of Coronary Artery Spasm Diagnosis in Patients With Early Repolarization Syndrome.

Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H, Nagase S, Noda T, Aiba T, Yasuda S, Shimizu W, Kamakura S, Kusano K.

J Am Heart Assoc. 2018 Feb 7;7(4). pii: e007942. doi: 10.1161/JAHA.117.007942.

13.

Efficacy of Octacalcium Phosphate Collagen Composite for Titanium Dental Implants in Dogs.

Kawai T, Matsui K, Ezoe Y, Kajii F, Suzuki O, Takahashi T, Kamakura S.

Materials (Basel). 2018 Feb 2;11(2). pii: E229. doi: 10.3390/ma11020229.

14.

Feasibility of drugs in Brugada syndrome: Authors' reply.

Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H, Nagase S, Noda T, Aiba T, Yasuda S, Shimizu W, Kamakura S, Kusano K.

Europace. 2018 Jun 1;20(FI1):f137. doi: 10.1093/europace/euy002. No abstract available.

PMID:
29351608
15.

Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.

Inoue YY, Aiba T, Kawata H, Sakaguchi T, Mitsuma W, Morita H, Noda T, Takaki H, Toyohara K, Kanaya Y, Itoi T, Mitsuhashi T, Sumitomo N, Cho Y, Yasuda S, Kamakura S, Kusano K, Miyamoto Y, Horie M, Shimizu W.

Europace. 2018 Oct 1;20(10):1675-1682. doi: 10.1093/europace/eux351.

PMID:
29309601
16.

Change in QRS morphology as a marker of spontaneous elimination in verapamil-sensitive idiopathic left ventricular tachycardia.

Kawakami H, Aiba T, Ishibashi K, Nakajima I, Wada M, Kamakura T, Inoue Y, Miyamoto K, Okamura H, Nagase S, Noda T, Kokubo Y, Miyamoto Y, Yasuda S, Kamakura S, Kusano K.

J Cardiovasc Electrophysiol. 2018 Mar;29(3):446-455. doi: 10.1111/jce.13403. Epub 2018 Jan 5.

PMID:
29226995
17.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group.

Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Erratum in: Lancet Neurol. 2017 Dec;16(12 ):954.

PMID:
29066163
18.

Feasibility evaluation of long-term use of beta-blockers and calcium antagonists in patients with Brugada syndrome.

Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H, Nagase S, Noda T, Aiba T, Yasuda S, Shimizu W, Kamakura S, Kusano K.

Europace. 2018 Jun 1;20(FI1):f72-f76. doi: 10.1093/europace/eux198.

PMID:
29036457
19.

Clinical outcome of patients with the Brugada type 1 electrocardiogram without prophylactic implantable cardioverter defibrillator in primary prevention: a cumulative analysis of seven large prospective studies.

Delise P, Probst V, Allocca G, Sitta N, Sciarra L, Brugada J, Kamakura S, Takagi M, Giustetto C, Calo L.

Europace. 2018 Jun 1;20(FI1):f77-f85. doi: 10.1093/europace/eux226.

20.

Single-dose local administration of teriparatide with a octacalcium phosphate collagen composite enhances bone regeneration in a rodent critical-sized calvarial defect.

Kajii F, Iwai A, Tanaka H, Matsui K, Kawai T, Kamakura S.

J Biomed Mater Res B Appl Biomater. 2018 Jul;106(5):1851-1857. doi: 10.1002/jbm.b.33993. Epub 2017 Sep 18.

Supplemental Content

Loading ...
Support Center